Global Hospital-Acquired Disease Testing Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Global Hospital-Acquired Disease Testing Market held USD 1108.6 million in 2020 and is to grow with a CAGR of over 19.8% from 2020-2030. Hospital-acquired disease and nosocomial infection is a localized or general condition in patients that occurs during medical care due to adverse reactions caused by infectious toxin agents, which were absent at admission in hospitals. Hospital-acquired infections result in prolonged hospital stay, resistance to antimicrobials, long-term disabilities and increased mortality rates. Hospital-acquired disease-causing pathogens include viruses, fungal parasites and bacteria. Hospital-acquired diseases also include catheter-related infections of the blood stream, infections of the surgical site, ventilator-associated pneumonia, and urinary tract-associated infection.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020394
Market Dynamics and Factors :
Major driving factors for the market are increased government spending on the healthcare and medical sector, growth of hospital infrastructure in developing economies. Rapid and effective infection detection solutions not only help control the incidence of nosocomial infections but also control overall medical costs, hospital stays and death. Widespread availability of more sophisticated solutions for detecting infections, especially those under molecular diagnostics, and their proven efficiency in delivering faster results has resulted in increased demand for such products worldwide. Government initiatives and hospital-acquired infection control authorities focusing on boosting awareness about hospital-acquired infection and available therapies further drive demand for hospital-acquired infection tests. Furthermore, increasing prevalence of hospital acquired infections and growth in drug resistant pathogens is anticipated to drive the hospital acquired infection testing market trends.
Market Segmentation:
Global Hospital-acquired disease testing Market – By Testing Type
Urinary Tract Infection
Surgical Site Infection
Pneumonia Stents
Blood Stream Infection
Methicillin-resistant Staphylococcus Aureus (MRSA))
Others
Global Hospital-acquired disease testing Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020394
Geographic Analysis :
North America dominates the hospital-acquired disease testing market share with the large demand owing to advanced healthcare infrastructure. As per U.S. Department of Health and Human Services, hospital acquired infection prevention costs nearly around US$ 28.0 Bn to US$ 33.0 Bn per year. Therefore, to lower the burden on hospitals occurring due to prolonged patients stay in hospitals, many governments are taking steps to lower hospital acquired infection prevalence in the particular countries.
Competitive Scenario :
Global hospital-acquired disease testing market, is highly competitive, consists of a few major players. In terms of market share, currently few players hold the majority of the hospital-acquired disease testing market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this drug globally. Key players enhancing the global Hospital-acquired disease testing market size include Hologic, Inc, bioMérieux SA, Abbott Laboratories, Siemens Healthcare, Alere, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hoffmann-La Roche Ltd, Diatherix Laboratories, Inc., Meridian Bioscience, Inc.
In 2019, F.Hoffmann-La Roche Ltd. grabbed U.S.. Food and Drug Administration (FDA) approval for a diagnostic test designed to detect the Methicillin-resistant Staphylococcus aureus (MRSA) bacteria, known as cobas vivoDx MRSA. The approval of is intended to control and prevent Methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in patients after long stay in hospitals.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020394
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Hospital-Acquired Disease Testing industry, although key threats, opportunities and disruptive technologies that could shape the Global Hospital-Acquired Disease Testing Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Hospital-Acquired Disease Testing Market most.
The data analysis present in the Global Hospital-Acquired Disease Testing Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Hospital-Acquired Disease Testing Market business.
The 2021 Annual Global Hospital-Acquired Disease Testing Market offers:
100+ charts exploring and analysing the Global Hospital-Acquired Disease Testing Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Hospital-Acquired Disease Testing Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020394
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/